DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$234.38
+1.86%Forward multiples
Based on analyst estimates
- P/E forward
- 25.77x
- P/E 2026E
- 27.09x
- P/E 2027E
- 24.98x
- P/E 2028E
- 22.72x
- P/S forward
- 5.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.30x
- PEG TTM
- 0.78x
- Price / book
- 3.08x
- Price / sales
- 6.44x
- Price / cash flow
- 24.04x
Enterprise value
- Enterprise value
- $185.7B
- EV / sales
- 7.25x
- EV / EBITDA
- 26.20x
- EV / EBIT
- 35.59x
- Market cap
- $164.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026